Enhancing the Prefusion Conformational Stability of SARS-CoV-2 Spike Protein Through Structure-Guided Design

Area of Science:

• Virology
• Structural Biology
• Immunology

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, necessitates adaptable vaccines due to viral mutations.
• Current SARS-CoV-2 therapies face challenges with long-term efficacy and broad applicability.
• The dynamic trimeric structure of the Spike protein complicates therapeutic development.

Purpose of the Study:

• To design novel, stable SARS-CoV-2 Spike protein constructs.
• To maintain the Spike protein in its immunogenically relevant prefusion state.
• To facilitate the development of vaccines and antibodies effective against viral evolution.

Main Methods:

• Rational design of Spike protein constructs guided by structural data.
• Engineering for enhanced stability and locking in the prefusion conformation.
• Focusing on the conserved S2 region and Receptor Binding Domains (RBD).

Main Results:

• Achieved uniquely high stability profiles for designed Spike constructs.
• Maintained the prefusion state of the engineered Spike trimers.
• Demonstrated a strategy linking conserved regions to dynamic domains for therapeutic potential.

Conclusions:

• Engineered Spike proteins offer a promising platform for next-generation COVID-19 vaccines.
• The design approach addresses viral mutation challenges by stabilizing key immunogenic regions.
• This work enables the development of broadly protective antibodies and vaccines.